CD19 and leukemia: Significantly however, we find that, upon repeated exposure to antigen and adoptive transfer to tumor-bearing mice, 19-28z-CAR transduced human T cells display enhanced expansion and greater in vivo anti-leukemia efficiency than CD19-targeted T cells that are costimulated through CD28/CD80.